Biotech Supplier Abcam’s Founder Threatens to Reignite Board Battle
- Jonathan Milner had asked to be named executive chairman
- Life sciences company is in talks about a potential sale
This article is for subscribers only.
Abcam Plc founder Jonathan Milner is threatening to resume a boardroom battle at the biotechnology supplier he started 25 years ago, weeks after the company said it would explore a sale.
Milner, who owns about 6.1% of Abcam, has been agitating for change at the company, asking to be named executive chairman alongside the removal of three directors. Milner argued in an open letter to shareholders on May 30 that Abcam’s incumbents lacked a “shareholder mindset” — and urged them to seek a buyer.